Home Tags DolaLock payload technology

Tag: DolaLock payload technology

FDA Clears Mersana’s IND Application for XMT-1536

Focusing on discovering and developing a pipeline of novel antibody-drug conjugates or ADCs based on its proprietary Dolaflexin® platform, Mersana Therapeutics' Investigational New Drug...

Preclinical Data Supports the Development of XMT-1536 in a Broad Population...

Update data from preclinical studies with XMT-1536, an antibody-drug conjugates or ADC being developed by Mersana Therapeutics targeting NaPi2b, were presented in a poster...

XMT-1522 Trial in Progress Data Presented at ASCO

Data from a trials in progress abstract presented during the 2017 annual meeting of the American Society of Clinical Oncology (ASCO) confirmed the continued...

X